J. Stern & Co. LLP Dexcom Inc Transaction History
J. Stern & Co. LLP
- $840 Billion
- Q2 2024
A detailed history of J. Stern & Co. LLP transactions in Dexcom Inc stock. As of the latest transaction made, J. Stern & Co. LLP holds 10,881 shares of DXCM stock, worth $746,545. This represents 0.15% of its overall portfolio holdings.
Number of Shares
10,881
Previous 2,487
337.52%
Holding current value
$746,545
Previous $345 Million
257.65%
% of portfolio
0.15%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding DXCM
# of Institutions
1,057Shares Held
358MCall Options Held
4.11MPut Options Held
3.63M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.19 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.37 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.12 Billion0.08% of portfolio
-
Baillie Gifford & CO15MShares$1.03 Billion0.77% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$820 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $26.5B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...